- Home
- CLDX vs SSII Comparison
CLDX vs SSII Comparison
Compare CLDX & SSII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- SSII
- Stock Information
- Founded
- CLDX N/A
- SSII N/A
- Country
- CLDX United States
- SSII India
- Employees
- CLDX N/A
- SSII N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- SSII
- Sector
- CLDX Health Care
- SSII
- Exchange
- CLDX Nasdaq
- SSII Nasdaq
- Market Cap
- CLDX 1.6B
- SSII 1.4B
- IPO Year
- CLDX 2008
- SSII N/A
- Fundamental
- Price
- CLDX $26.22
- SSII $6.67
- Analyst Decision
- CLDX Strong Buy
- SSII
- Analyst Count
- CLDX 8
- SSII 0
- Target Price
- CLDX $46.13
- SSII N/A
- AVG Volume (30 Days)
- CLDX 1.1M
- SSII 63.3K
- Earning Date
- CLDX 11-05-2025
- SSII 11-14-2025
- Dividend Yield
- CLDX N/A
- SSII N/A
- EPS Growth
- CLDX N/A
- SSII N/A
- EPS
- CLDX N/A
- SSII N/A
- Revenue
- CLDX $5,790,000.00
- SSII $27,623,624.00
- Revenue This Year
- CLDX N/A
- SSII N/A
- Revenue Next Year
- CLDX N/A
- SSII N/A
- P/E Ratio
- CLDX N/A
- SSII N/A
- Revenue Growth
- CLDX N/A
- SSII 134.89
- 52 Week Low
- CLDX $14.40
- SSII $2.48
- 52 Week High
- CLDX $31.66
- SSII $22.42
- Technical
- Relative Strength Index (RSI)
- CLDX 60.30
- SSII 54.09
- Support Level
- CLDX $24.49
- SSII $6.23
- Resistance Level
- CLDX $26.90
- SSII $7.74
- Average True Range (ATR)
- CLDX 1.00
- SSII 0.67
- MACD
- CLDX 0.07
- SSII 0.15
- Stochastic Oscillator
- CLDX 79.27
- SSII 59.85
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About SSII SS Innovations International Inc.
SS Innovations International Inc is a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. The company designs, manufactures, and markets an advanced, next-generation, and affordable surgical robotic system called the SSi Mantra, and the instruments and accessories used with SSi Mantra to perform a wide range of soft-tissue, robotically assisted surgeries. The company earns the majority of its revenue from India.